Skip to main content
logo
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
89.27
-0.04 (-0.04%)
At close: Mar 20, 2026, 4:00 PM EDT
90.93
+1.66 (1.86%)
After-hours: Mar 20, 2026, 7:32 PM EDT

BioNTech SE Revenue

In the year 2025, BioNTech SE had annual revenue of 2.87B EUR with 4.32% growth. BioNTech SE had revenue of 907.40M in the quarter ending December 31, 2025, a decrease of -23.75%.

Revenue (ttm)
2.87B EUR
Revenue Growth
+4.32%
P/S Ratio
6.66
Revenue / Employee
367,606 EUR
Employees
7,807
Market Cap
22.44B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.87B118.80M4.32%
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.34B
Incyte5.14B
Genmab3.72B
Alnylam Pharmaceuticals3.71B
Royalty Pharma2.38B
Moderna1.94B
Ascendis Pharma845.52M
Insmed606.42M
Revenue Rankings

BNTX News

More News